Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00762567 · ClinicalTrials.gov registry record · Phase 1
Phenylephrine Pediatric Pharmacokinetic Study
A Phase 1 study, sponsored by Johnson & Johnson Consumer and Personal Products Worldwide.
- Completed
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
NCT00762567 is a Phase 1 study that has completed, run by Johnson & Johnson Consumer and Personal Products Worldwide. The registered enrollment target is 36 participants.
The verdict
NCT00762567, a Phase 1 study, has completed, sponsored by Johnson & Johnson Consumer and Personal Products Worldwide.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
Study Summary
To characterize the pharmacokinetics of phenylephrine in two pediatric populations: children, ages 2 to \<12 years, and adolescents, ages 12 to \<18 years.
Interventions
- DRUG phenylephrine HCl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2008-09 |
| Est. Completion | 2008-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00762567
The ClinicalTrials.gov registry entry for NCT00762567 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Consumer and Personal Products Worldwide, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which phenylephrine HCl is the first listed.
NCT00762567 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00762567 about?
NCT00762567 is a clinical study titled "Phenylephrine Pediatric Pharmacokinetic Study". To characterize the pharmacokinetics of phenylephrine in two pediatric populations: children, ages 2 to \<12 years, and adolescents, ages 12 to \<18 years.
What is the current status of trial NCT00762567?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2008-09. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00762567?
The interventions under investigation include: phenylephrine HCl (DRUG).
Who is sponsoring clinical trial NCT00762567?
This trial is sponsored by Johnson & Johnson Consumer and Personal Products Worldwide, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.